Put your patients in better control.

Powerful.
Proven.
Protective.

The smart CGM solution for your
insulin-using patients.

Learn About Dexcom G6
Video

Doctor Testimonials
See All Videos

Real-time
Continuous
Glucose
Data 24/7

The only provider of CGMs that
give patients and their followers
continuous readings every
five minutes, every day.

Read About Dexcom G6

Prescribe
Dexcom CGM
Today.

A retail pharmacy prescription can be the
fastest and easiest way to start your
patients on a Dexcom CGM.

Prescribe Dexcom G6
Powerful. Proven. Protective. Dexcom
Dexcom G6 Real-time CGM
Prescribe Dexcom CGM Today

Protective Features1-3

Accuracy

Dexcom G6 features an overall MARD† of 9.0.4

RT-CGM

Real-time continuous glucose readings are sent straight to your patient's smart device or receiver every five minutes.

More Followers

Real-time glucose data can be shared with up to ten followers, increasing a patient's circle of support.

Indicated for 2 Years
and Older

Dexcom is the only provider of CGM systems indicated for children ages 2 years and older.

Customizable Alerts

Two customized alert schedules can be set within a 24-hour period, giving patients more peace of mind and discretion, whether they are sleeping, exercising or in a business meeting.

Urgent Low
Soon Alert

The urgent low soon can warn patients in advance of a potential severe hypoglycemic event (55 mg/dL)—allowing them time to take appropriate action before it happens.

Dexcom_G6_CGM

View Dexcom Products

Proven Outcomes

Review the novel COMISAIR Study, as well as other clinical evidence
and professional society guidelines demonstrating the
benefits of Dexcom Continuous Glucose Monitoring (CGM).

See Clinical Evidence

Powerful Stories

Dr. Anita Swamy | Endocrinologist

Providers play a vital role in diabetes treatment, education, training and access to care for millions of Americans. Dexcom remains committed to empowering providers with the best technology and resources for diabetes management. Hear why Endocrinologist Dr. Anita Swamy believes in Dexcom G6.

Dr. Swamy is a paid spokesperson of Dexcom, Inc.

See Story      See all Spotlights

Dr_Swamy

Dexcom News & Events

May 2 2019

ADA 2019: CME-Certified Symposium and Dexcom Product Theater

  Dexcom Product Theater: Innovations in Dexcom CGM Technology for the Patient and the Professional This product theater will teach participants the role of CGM and its clinical benefit for patients, as well as real-time insulin dosing methods ...

Learn More

See all News and Events

†MARD is a statistical measure of accuracy.
1Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA. 2017; 317(4); 371-378.
2Heinemann L, Freckmann G, Ehrmann D, et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 2018; 391(10128):1367-1377.
3Puhr S, Derdzinski M, Welsh JB, Parker AS, Walker T, Price DA. Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert. Diabetes Technol Ther. 2019; 21(4):155-158.
4Dexcom G6 CGM System User Guide, 2018.

Contact Dexcom

If you are a clinician and want to learn more about Dexcom’s Continuous Glucose Monitoring Systems, please fill out the form and a Dexcom representative will contact you.

If you are a Dexcom User or Patient, please contact Dexcom here.

The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.